Sign in
Taking people in United StatesNo phase

Cereset device for stress, anxiety or trouble sleeping

Tests the Cereset device on body stress responses in people with stress, anxiety or insomnia.

Key facts

Who runs it
Wake Forest University Health Sciences
Where
Winston-Salem, United StatesSee the site
Trial code
Registry title
Cereset Research Exploratory Study
Status
Recruiting
People taking part
200 people, planned
Started
12 Apr 2019
Expected to end
Apr 2028
Type of study
Interventional
Treatments tested
  • Active CR
Record updated
20 July 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for people aged 11 or older with symptoms of stress, anxiety, or trouble sleeping (insomnia). It tests a device called Cereset Research.

Age
11 Years and older
Sex
All
Disease stage
Symptoms of stress, anxiety, or insomnia that reach set scores on at least one questionnaire: Insomnia Severity Index (ISI, ≥ 8), Perceived Stress Index (PSS, ≥ 14), or GAD-7 (≥ 5). You must be able to follow simple instructions and sit still with sensors attached.
Earlier treatment
Cannot join after HIRREM, Brainwave Optimization, Cereset, B2 or B2v2 in the last 3 years, or after any electroconvulsive therapy (ECT) ever. Cannot join after TMS, TDCS, alpha stimulation, neurofeedback, biofeedback or deep brain stimulation (DBS) in the month before joining.

Main reasons for not taking part

  • Known seizure disorder
  • Severe hearing loss
  • Weight over 285 pounds (129 kg)
  • Unable to come to visits or sit in a chair for up to 1.5 hours
  • Currently in another active treatment research study

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • Subjects must have the ability to comply with basic instructions and be able to sit still comfortably with the sensor leads attached
  • Subjects experiencing symptoms of stress, anxiety, or insomnia, who meet threshold scores on one or more self-reported inventories for the same. This includes the Insomnia Severity Index (ISI, ≥ 8), the Perceived Stress Index (PSS, ≥ 14), or the Generalized Anxiety Disorder 7-item (GAD-7, ≥ 5) scale

Who cannot take part

  • Prior use of HIRREM, Brainwave Optimization, Cereset, or a wearable configuration of the same (B2, or B2v2) within the last 3 years
  • Prior use of electroconvulsive therapy (ECT)
  • Prior use of transcranial magnetic stimulation (TMS), transcranial direct current stimulation (TDCS), alpha stimulation, neurofeedback, biofeedback, or deep brain stimulation (DBS) within one month before enrollment
  • Severe hearing impairment (because the subject will be using ear buds during CR)
  • Known seizure disorder
  • Unable, unwilling, or incompetent to provide informed consent/assent
  • Physically unable to come to the study visits, or to sit comfortably in a chair for up to 1.5 hours
  • Weight is over the chair limit (285 pounds)
  • Currently in another active intervention research study

Where in United States

  • Wake Forest University Health Scienc\essWinston-Salem, United StatesContact: Kenzie BrownTaking people

About the trial

What the trial wants to find out

The purpose of this study is to evaluate the use of Cereset Research to improve autonomic function in participants with symptoms of stress, anxiety, or insomnia.

The group in the trial

  • Experimental: Active CRTreatment being tested

    For this single arm, open label, exploratory trial this will be the intervention arm using active CR.

    Treatment: Active CR

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Cereset Research Exploratory Study
Plain-language title
Cereset device for stress, anxiety or trouble sleepingGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
20 July 2026